Brief: IO Biotech Announces Achievement Of Phase 3 Clinical Trial Recruitment Milestone

IO Biotech

14/06/2023 13:51

June 14 (Reuters) - IO Biotech Inc  IOBT.O :
    * IO BIOTECH ANNOUNCES ACHIEVEMENT OF SIGNIFICANT PHASE 3
CLINICAL
TRIAL RECRUITMENT MILESTONE
    * IO BIOTECH INC - DATA OBTAINED FROM ANALYSIS, IF POSITIVE,
COULD
ALLOW FOR SUBMISSION OF BLA  FOR ACCELERATED APPROVAL IN UNITED
STATES
    * IO BIOTECH INC - CONTINUES TO EXPECT TO FULLY ENROLL TRIAL
BY
YEAR-END 2023 AND FOR ITS CURRENT CASH TO SUPPORT ACTIVITIES
THROUGH Q3 OF 2024
    * IO BIOTECH INC - IT IS INCREASING NUMBER OF PATIENTS TO BE
ENROLLED IN PHASE 3 TRIAL TO 380 PATIENTS

Source text for Eikon:  ID:nGNX34HW3d 
Further company coverage:  IOBT.O 

 (reuters.briefs@thomsonreuters.com)